BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33690230)

  • 1. RELA Fusion-Positive Ependymoma in a Child with Down Syndrome: A Case Report.
    Chan JL; Kashanian A; Bannykh SI; Majlessipour F; Breunig JJ; Danielpour M
    Pediatr Neurosurg; 2021; 56(2):146-151. PubMed ID: 33690230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel type of C11orf95-LOC-RELA fusion in a grade II supratentorial ependymoma: report of a case with literature review.
    de Sousa GR; Marie SKN; Oba-Shinjo SM; Ramalho LNZ; Tone LG; Valera ET
    Childs Nerv Syst; 2019 Apr; 35(4):689-694. PubMed ID: 30631904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C11orf95-RELA fusion present in a primary intracranial extra-axial ependymoma: Report of a case with literature review.
    Nambirajan A; Malgulwar PB; Sharma MC; Singh A; Pathak P; Satyarthee GD; Garg A
    Neuropathology; 2016 Oct; 36(5):490-495. PubMed ID: 27121356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ependymoma-like tumor with mesenchymal differentiation harboring C11orf95-NCOA1/2 or -RELA fusion: A hitherto unclassified tumor related to ependymoma.
    Tomomasa R; Arai Y; Kawabata-Iwakawa R; Fukuoka K; Nakano Y; Hama N; Nakata S; Suzuki N; Ishi Y; Tanaka S; Takahashi JA; Yuba Y; Shiota M; Natsume A; Kurimoto M; Shiba Y; Aoki M; Nabeshima K; Enomoto T; Inoue T; Fujimura J; Kondo A; Yao T; Okura N; Hirose T; Sasaki A; Nishiyama M; Ichimura K; Shibata T; Hirato J; Yokoo H; Nobusawa S
    Brain Pathol; 2021 May; 31(3):e12943. PubMed ID: 33576087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supratentorial ependymoma in childhood: more than just RELA or YAP.
    Zschernack V; Jünger ST; Mynarek M; Rutkowski S; Garre ML; Ebinger M; Neu M; Faber J; Erdlenbruch B; Claviez A; Bielack S; Brozou T; Frühwald MC; Dörner E; Dreschmann V; Stock A; Solymosi L; Hench J; Frank S; Vokuhl C; Waha A; Andreiuolo F; Pietsch T
    Acta Neuropathol; 2021 Mar; 141(3):455-466. PubMed ID: 33481105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extra-Ventricular C11orf95-RELA Fusion Positive Anaplastic Ependymoma with Divergent Histological and Immunohistochemical Features: Report of a Rare Case.
    Purkait S; Nayak M; Patnaik A; Patra S; Malgulwar PB
    Neurol India; 2021; 69(4):1060-1062. PubMed ID: 34507448
    [No Abstract]   [Full Text] [Related]  

  • 7. Supratentorial non-RELA, ZFTA-fused ependymomas: a comprehensive phenotype genotype correlation highlighting the number of zinc fingers in ZFTA-NCOA1/2 fusions.
    Tauziède-Espariat A; Siegfried A; Nicaise Y; Kergrohen T; Sievers P; Vasiljevic A; Roux A; Dezamis E; Benevello C; Machet MC; Michalak S; Puiseux C; Llamas-Gutierrez F; Leblond P; Bourdeaut F; Grill J; Dufour C; Guerrini-Rousseau L; Abbou S; Dangouloff-Ros V; Boddaert N; Saffroy R; Hasty L; Wahler E; Pagès M; Andreiuolo F; Lechapt E; Chrétien F; Blauwblomme T; Beccaria K; Pallud J; Puget S; Uro-Coste E; Varlet P;
    Acta Neuropathol Commun; 2021 Aug; 9(1):135. PubMed ID: 34389065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI Phenotype of RELA-fused Pediatric Supratentorial Ependymoma.
    Nowak J; Jünger ST; Huflage H; Seidel C; Hohm A; Vandergrift LA; von Hoff K; Rutkowski S; Pietsch T; Warmuth-Metz M
    Clin Neuroradiol; 2019 Dec; 29(4):595-604. PubMed ID: 30027327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RELA fusion-positive ependymoma accompanied by extensive desmoplasia: a case report.
    Fukushima T; Ueda T; Hirato J; Kataoka H
    Brain Tumor Pathol; 2020 Oct; 37(4):159-164. PubMed ID: 32754892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Immunohistochemistry in the Identification of Supratentorial C11ORF95-RELA Fused Ependymoma in Routine Neuropathology.
    Gessi M; Giagnacovo M; Modena P; Elefante G; Gianno F; Buttarelli FR; Arcella A; Donofrio V; Diomedi Camassei F; Nozza P; Morra I; Massimino M; Pollo B; Giangaspero F; Antonelli M
    Am J Surg Pathol; 2019 Jan; 43(1):56-63. PubMed ID: 29266023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C11orf95-RELA, YAP1-MAMLD1, and YAP1-FAM118B Fusion Negative Anaplastic Ependymoma with Lipogenic Differentiation.
    Jha S; Mulgulwar PB; Sharma MC; Purkait S; Pattnaik A; Sable MN
    Neurol India; 2023; 71(5):1011-1014. PubMed ID: 37929446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging.
    Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F
    Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encouraging option of multi-staged gross total resection for a C11orf-RelA fusion-positive supratentorial anaplastic ependymoma.
    Nakamura T; Fukuoka K; Ikeda J; Yoshitomi M; Udaka N; Tanoshima R; Tateishi K; Yamanaka S; Ichimura K; Yamamoto T
    Brain Tumor Pathol; 2017 Oct; 34(4):160-164. PubMed ID: 28831588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RELA fusion-positive anaplastic ependymoma: molecular characterization and advanced MR imaging.
    Onishi S; Yamasaki F; Nakano Y; Takayasu T; Amatya VJ; Kolakshyapati M; Takeshima Y; Hirose T; Ichimura K; Sugiyama K; Kurisu K
    Brain Tumor Pathol; 2018 Jan; 35(1):41-45. PubMed ID: 29063976
    [No Abstract]   [Full Text] [Related]  

  • 15. Supratentorial extra-axial RELA fusion-positive ependymoma misdiagnosed as meningioma by intraoperative histological and cytological examinations: a case report.
    Nagayasu MA; Fukushima T; Matsumoto F; Takeshima H; Sato Y; Kataoka H
    J Med Case Rep; 2022 Aug; 16(1):312. PubMed ID: 35986385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L1CAM Immunopositivity in Anaplastic Supratentorial Ependymomas: Correlation With Clinical and Histological Parameters.
    Chavali P; Rao S; Palavalasa S; Bevinahalli N; Muthane YTC; Sadashiva N; Santosh V
    Int J Surg Pathol; 2019 May; 27(3):251-258. PubMed ID: 30251576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C11orf95-RELA fusion drives aberrant gene expression through the unique epigenetic regulation for ependymoma formation.
    Ozawa T; Kaneko S; Szulzewsky F; Qiao Z; Takadera M; Narita Y; Kondo T; Holland EC; Hamamoto R; Ichimura K
    Acta Neuropathol Commun; 2021 Mar; 9(1):36. PubMed ID: 33685520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong OLIG2 expression in supratentorial ependymoma, ZFTA fusion-positive: A potential diagnostic pitfall.
    de Castro JVA; Kulikowski LD; Wolff BM; Natalino R; Carraro DM; Torrezan GT; Scapulatempo Neto C; Amancio CT; Canedo FSNA; Feher O; Costa FD
    Neuropathology; 2024 Apr; 44(2):167-172. PubMed ID: 37855183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TP53 p.R337H mutation is uncommon in a Brazilian cohort of pediatric patients diagnosed with ependymoma.
    de Almeida Magalhães T; Borges KS; de Sousa GR; Brandalise SR; Seidinger AL; Scrideli CA; Oba-Shinjo SM; Yunes JA; Tone LG
    Neurol Sci; 2020 Mar; 41(3):691-694. PubMed ID: 31728854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C11orf95-RELA reprograms 3D epigenome in supratentorial ependymoma.
    Zhu JJ; Jillette N; Li XN; Cheng AW; Lau CC
    Acta Neuropathol; 2020 Dec; 140(6):951-960. PubMed ID: 32909151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.